Tharimmune Stock (NASDAQ: THAR) stock price, news, charts, stock research, profile.
Open | $3.80 |
Close | $3.74 |
Volume / Avg. | 8.32K / 44.21K |
Day Range | 3.65 - 3.80 |
52 Wk Range | 2.75 - 2.14K |
Market Cap | $2.99M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 23 |
Short Interest | 6.48% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Tharimmune (NASDAQ:THAR) through any online brokerage.
Other companies in Tharimmune’s space includes: Alzamend Neuro (NASDAQ:ALZN), Dermata Therapeutics (NASDAQ:DRMA), Entero Therapeutics (NASDAQ:ENTO), Quoin Pharmaceuticals (NASDAQ:QNRX) and Cyclacel Pharmaceuticals (NASDAQ:CYCC).
There is no analysis for Tharimmune.
There is no analysis for Tharimmune to provide a consensus price target.
The stock price for Tharimmune (NASDAQ: THAR) is $3.8 last updated July 19, 2024 at 7:57 AM EDT.
There are no upcoming dividends for Tharimmune.
Tharimmune’s Q2 earnings are confirmed for Friday, August 9, 2024.
There is no upcoming split for Tharimmune.
Tharimmune is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.